Immunogenic composition

Compositions relating to a mutant toxin and methods thereof

NOVEL MUCOSAL ADJUVANTS AND DELIVERY SYSTEMS

Method of treating depression

HUMAN ANTIBODY SPECIFIC TO TOXIN PRODUCED FROM CLOSTRIDIUM DIFFICILE, OR ANTIGEN-BINDING FRAGMENT THEREOF

Method of storing a vaccine containing an aluminum adjuvant

Re-directed immunotherapy

Immunogenic composition

Immunogenic compositions

Bacterial live vector vaccines expressing chromosomally-integrated foreign antigens

PEGylated mutated toxin

POLYSACCHARIDE COMPOSITIONS AND METHODS OF USE

Toxin in type A

Method of producing a designer blood product, method of using a designer blood product, and diet for selectively enhancing blood profile

Oil-based adjuvants

toxoid vaccine

Clostridium difficile toxin-based vaccine

Vaccine and uses thereof

Compositions relating to a mutant toxin and methods thereof

Active self-healing biomaterial system

Anti-C. difficile toxin antibodies and associated methods

antigens

Compositions and methods for enhancing metal ion dependent drug therapies

Diabetes-inducible bacterium

IMMUNOLOGICAL COMPOSITION FOR CLOSTRIDIUM DIFFICILE

PROCESS FOR THE PREPARATION AND USE OF A BIVALENT VACCINE AGAINST MORPHINE-HEROIN ADDICTION

Epsilon toxin epitopes from with reduced toxicity

Isolated polypeptide of the toxin A and toxin B proteins of and uses thereof

MULTIVALENT NANOEMULSION VACCINES

Bacterial vaccine

Immunogenic composition

Vaccines against clostridium difficile comprising recombinant toxins

Conjugating amines

IMMUNIZATION AGAINST CLOSTRIDIUM DIFFICILE DISEASE

Methods for potentiating immune response for the treatment of infectious diseases and cancer

Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency

Mucosal vaccine using cationic nanogel

Method for formulating a vaccine containing at least two antigens capable of adsorbing onto aluminium oxyhydroxide

Liposomal vaccine adjuvants and methods of making and using same

Clostridium difficile DNA vaccine

West Nile Virus vaccine

ORF2 PROTEIN OF PCV2 SUBTYPE A (PCV2A) FOR USE IN CROSS-PROTECTION

Recombinant poxvirus vector comprising tetanus toxin fragment C

lipoteichoic acid and uses thereof

Vaccine

MANUFACTURE OF VACCINES THAT CONTAIN BOTH HEPATITIS B VIRUS SURFACE ANTIGEN AND SURFACTANT

TRANSCUTANEOUS DELIVERY OF THERAPEUTIC AGENTS

COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTS

NOVEL TYPE 1 DIABETES VACCINES, AND METHODS OF USE

Compositions and methods for treating clostridium difficile-associated diseases

Vaccine composition with aluminium hydroxide nanoparticles

Hypo- and hyper-acetylated meningococcal capsular saccharides

Engineered type IV pilin of

Immunization compositions and methods

POLYPEPTIDE-VACCINES FOR BROAD PROTECTION AGAINST HYPERVIRULENT MENINGOCOCCAL LINEAGES

Multivalent vaccines for rabies virus and filoviruses

Immunogenic composition

Aminophosphinic derivatives that can be used in the treatment of pain

Process for stabilizing an adjuvant containing vaccine composition

Pathogenic bacteria

Adjuvant incorporation in immunoanotherapeutics

Vaccines for suppressing IgE-mediated allergic disease and methods for using the same

Antibodies against clostridium difficile toxins and uses thereof

Vaccine and drug delivery by intranasal application of vector and vector extracts

Immunogenic composition

Compositions and methods for enhancing metal ion dependent drug therapies

Neurotoxins exhibiting shortened biological activity

VACCINES AGAINST CLOSTRIDIUM DIFFICILE AND METHODS OF USE

NOVEL METHOD

PROCESS FOR PRODUCING AN IMMUNOGENIC COMPOSITION CONTAINING TETANUS TOXOID

Method for the production of protein complexes and vaccine compositions comprising the same

Vaccine injection, preparation method and use thereof

Re-directed immunotherapy

OLIGOSACCHARIDES AND OLIGOSACCHARIDE-PROTEIN CONJUGATES DERIVED FROM CLOSTRIDIUM DIFFICILE POLYSACCHARIDE PS-II, METHODS OF SYNTHESIS AND USES THEREOF, IN PARTICULAR AS A VACCINE

Engineered type IV pilin of

Reduction Of Antibody Response Against Botulinum Neurotoxin And Variants Thereof

COMPOUNDS

Vaccine against

Combination heptavalent vaccine

Medicament for LCT poisoning

Methods and compositions for intranasal delivery

antigens

Formulation suitable for stabilizing proteins, which is free of mammalian excipients

Compositions and methods for topical application and transdermal delivery of botulinum toxins

Method of treating depression

Recombinant vaccine against infection and epsilon toxin intoxication

Immunization against disease

Immunogenic composition

Recombinant HCMV and RHCMV vectors and uses thereof

Adjuvant incorporation in immunonanotherapeutics

Use of botulinum neurotoxin to alleviate various disorders

Methods and compositions for intranasal delivery

S-nitrosylation of glucosylating toxins and uses therefor

Multiple vaccination including serogroup C meningococcus

Multiple vaccination including serogroup C meningococcus

Process for manufacturing vaccines

Botulinum neurotoxin antigenic compositions and methods

ACTIVE SELF-HEALING BIOMATERIAL SYSTEM

Antibodies against clostridium difficile toxins and uses thereof

Multivalent live vector vaccine against -associated disease

Atoxic recombinant holotoxins of Clostridium difficile as immunogens

Compositions relating to a mutant toxin and methods thereof

IMMUNOGENIC COMPOSITIONS COMPRISING NANOEMULSION AND HEPATITIS B VIRUS IMMUNOGEN AND METHODS OF USING THE SAME

Pharmaceutical compositions containing botulinum neurotoxin

Bacterial spore having therapeutic agent adsorbed on its surface

Botulinum toxin treatments

Transdermal delivery system for therapeutics

Transcutaneous immunization without heterologous adjuvant

Peptide, adjuvants, vaccines, and methods of use

Vaccines with increased immunogenicity and methods for obtaining them

Formulation of immunopotentiators

Use of vitelline protein B as a microencapsulating additive

Skin cosmesis treatment with clostridia neurotoxins

Monoclonal antibodies to dendritic cells

TREATMENT OF HOLOCRINE GLAND DYSFUNCTION WITH CLOSTRIDIA NEUROTOXINS

Neurotoxins exhibiting shortened biological activity

Albumin-Free Botulinum Toxin Formulations

Multivalent nanoemulsion vaccines

Combination vaccines with low dose of Hib conjugate

Manufacture of vaccines that contain both hepatitis B virus surface antigens and surfactant

Method of storing a vaccine containing an aluminum adjuvant

Movable wall panel system with electrical connections

Polysaccharide-protein conjugate vaccines

Engineered type IV pilin of

Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells

SOLID DISPERSING VACCINE COMPOSITION FOR ORAL DELIVERY

Proteins with improved solubility and methods for producing and using same

Use of a botulinum neurotoxin to alleviate various disorders

Genetically engineered clostridial genes, proteins encoded by the engineered genes, and uses thereof

VACCINES AGAINST CLOSTRIDIUM DIFFICILE AND METHODS OF USE

CLOSTRIDIUM TAENIOSPORUM SPORES AND SPORE APPENDAGES AS SURFACE DISPLAY HOSTS, DRUG DELIVERY DEVICES, AND NANOBIOTECHNOLOGICAL STRUCTURES

VACCINE AGAINST BOTULISM

Process for the preparation and use of a bivalent vaccine against morphine-heroine addiction

Compositions and dosage regimes comprising a clostridial vaccine and levamisole

Mixing lyophilised meningococcal vaccines with D-T-Pa vaccines

Multiple vaccination including serogroup C Meningococcus

PEGylated mutated toxin

polypeptide, DNA encoding the polypeptide and a vaccine comprising the polypeptide

Helicobacter system and uses thereof

Adjuvant incorporation in immunonanotherapeutics

SINGLE-TIME VACCINES

PROCESS FOR PRODUCTION OF VACCINES

Vaccines

MUCOSAL VACCINE USING CATIONIC NANOGEL

Combination vaccine with acellular pertussis

COMBINATION VACCINE WITH WHOLE CELL PERTUSSIS

Immunization compositions and methods

Methods of immunizing pregnant heifers at three months of gestation

Subtype of neurotoxin type A and uses thereof

STABLE POWDER FORMULATIONS OF ALUM-ADSORBED VACCINES

West Nile Virus vaccine

Pharmaceutical compositions containing botulinum toxin

Transcutaneous delivery of therapeutic agents

Aminophosphinic derivatives that can be used in the treatment of pain

Nanoscale Adjuvants and Related Pharmaceutical Compositions and Methods

Immunogenic compositions for gram positive bacteria such as

Methods, compositions and kits for vegetative cell-based vaccines and spore-based vaccines

Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins

Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine

High affinity human antibodies to PCSK9

Cell membrane translocation of regulated snare inhibitors, compositions therefor, and methods for treatment of disease

Pharmaceutical compositions containing toxoids A and B

Recombinant toxin fragments

PROCESS FOR TREATMENT OF RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS

Recombinant attenuated clostridium organisms and vaccine

SOLID DISPERSING VACCINE COMPOSITION FOR ORAL DELIVERY

Compositions and methods for enhancing metal ion dependent drug therapies

Oral delivery of tetanus toxoid

Polysaccharide immunogens from

Albumin-free botulinum toxin formulations

BOTULINUM NEUROTOXIN VACCINE

Chemically modified peptides with improved immunogenicity

PHARMACEUTICAL COMPOSITION FOR THE SUBLINGUAL ADMINISTRATION OF VACCINES, METHOD FOR THE PREPARATION OF THE SAME AND USES THEREOF

Macrocyclic lactone combination compositions, vaccines and methods for producing same

alpha toxin proteins

Vaccine against

Method for treating depression

Composition and method for controlling intestinal pathogenic organisms

Mutant botulinum neurotoxin serotype A polypeptide and uses thereof

Antibodies against toxins and uses thereof

Antibodies against clostridium difficile toxins and uses thereof

COMBINATION VACCINES WITH 1-HYDROXY-2-PHENOXYETHANE PRESERVATIVE

Process for manufacturing vaccines

Treating neoplasms with neurotoxin

Use of a botulinum neurotoxin to alleviate various disorders

Genetically engineered clostridial genes, proteins encoded by the engineered genes, and uses thereof

Recombinant attenuated organisms and vaccine

High affinity human antibodies to PCSK9

Method of preparing an immunologically-active adjuvant-bound dried vaccine composition

MANUFACTURE OF BOOSTER VACCINES HAVING REDUCED ANTIGEN DOSES

METHODS AND COMPOSITIONS FOR VACCINATION OF POULTRY

Extracellular Matrix Materials as Vaccine Adjuvants for Diseases Associated with Infectious Pathogens or Toxins

METHODS AND COMPOSITIONS FOR VACCINATION OF POULTRY

Adjuvant incorporation in immunonanotherapeutics

Method for genetic immunization by electrotransfer against a toxin and antiserum obtainable by said method

Early Treatment and Prevention of Increased Muscle Tonicity

Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin B peptides

Determining and Reducing Immunoresistance to a Botulinum Toxin Therapy Using Botulinum Toxin B Peptides

Determining and reducing immunoresistance to a toxin therapy using toxin B peptides

Multi component vaccine containing clostridial and non-clostridial organisms in a low dose

Determining and Reducing Immunoresistance to a Botulinum Toxin Therapy Using Botulinum Toxin B Peptides

Hypo- and Hyper- Acetylated Meningococcal Capsular Saccharides

PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS

VACCINE

Use of Clostridium perfringens type C bacterium for the manufacture of a vaccine

Biologically active hemagglutinin from type a and methods of use

Inactivated polio vaccines

Vaccine

Multiple vaccination including serogroup C meningococcus

Immunogenic compositions comprising nanoemulsion and hepatitis B virus immunogen and methods of using the same

Controlled-release immunogenic formulations to modulate immune response

IPV-DPT vaccine

Use of the neurotoxic component of a botulinum toxin for treating arthritis

Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae

MEDICAMENT FOR LCT POISONING

Composition and Methods for Immunisation Using CD1D Ligands

Recombinant toxin fragments

Proteins with Improved Solubility and Methods for Producing and Using Same

RESPONSES TO IMMUNIZATIONS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH A CD20 ANTIBODY

Immunogenic composition

Recombinant toxin fragments

Process for stabilizing an adjuvant containing vaccine composition

system and uses thereof

Combination vaccines with low dose of hib conjugate

Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine

Manufacturing Method of Combined Vaccine

Expressing hepatitis B virus surface antigen for vaccine preparation

Detoxified recombinant botulinum neurotoxin

Manufacture of Vaccines That Contain Both Hepatitis B Virus Surface Antigen and Surfactant

Recombinant toxin fragments

Immunogenic composition

COMBINATION VACCINE

TREATMENT OF POST-STROKE MUSCLE PAIN

Pegylated mutated clostridium botulinum toxin

Dry Formulation for Transcutaneous Immunization

DETOXIFICATION METHOD

Immunogenic composition

Treating neoplasms with neurotoxin

-derived vaccine and therapy against botulism

Conjugate Vaccines

Methods and compositions involving polymeric immunoglobulin fusion proteins

COMPOSITION AND METHOD FOR CONTROLLING INTESTINAL PATHOGENIC ORGANISMS

Process for the preparation and use of a bivalent vaccine against morphine-heroine addiction

STABLE POWDER FORMULATIONS OF ALUM-ADSORBED VACCINES

Botulinum toxin treatments

BOTULINUM TOXIN TREATMENTS

Determining and reducing immunoresistance to a Botulinum toxin therapy using Botulinum toxin B peptides

Sustained release vaccine composition

Immunogenic composition

Immunogenic composition

Identification and characterization of novel proline racemases and hydroxyproline-2-epimerases, uses thereof, and methods of identifying proline racemases and hydroxyproline-2-epimerases

Use of a botulinum neurotoxin to alleviate various disorders

DETERMINING AND REDUCING IMMUNORESISTANCE TO A BOTULINUM TOXIN THERAPY USING BOTULINUM TOXIN B PEPTIDES

PHARMACEUTICAL COMPOSITIONS CONTAINING BOTULINUM TOXIN

USE OF THE NEUROTOXIC COMPONENT OF A BOTULINUM TOXIN FOR TREATING A SPASTIC MUSCLE

NEUROTOXIN COMPONENT TREATMENT FOR SPASTICITY

Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins

Polynucleotides encoding alpha toxin proteins

Use of the Neurotoxic Component of a Botulinum Toxin

Mucosal vaccine adjuvants containing bacterial flagellins as an active component

Method of vaccinating subjects receiving immune modulating therapy

SOLID DISPERSING VACCINE COMPOSITION FOR ORAL DELIVERY

METHOD FOR TREATING SMOOTH MUSCLE DISORDERS WITH A NEUROTOXIC COMPONENT OF A BOTULINUM TOXIN

NEUROTOXIC COMPONENT OF A BOTULINUM TOXIN

Recombinant attenuated organisms and vaccine

Vaccines

Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin B peptides

Tolerogizing compositions comprising botulinum toxin type B peptides

Inducible Bacterial Expression System Utilising Sspa Promoter from Salmonella

Determining and Reducing Immunoresistance to Botulinum Toxin Therapy Using Botulinum Toxin a Peptides

Recombinant toxin fragments

Methods and compositions for vaccination of poultry

Methods and compositions for vaccination of poultry

West Nile vaccine

West nile DNA vaccine

Immunization Against Clostridium Difficile Disease

USE OF THE NEUROTOXIC COMPONENT OF A BOTULINUM TOXIN FOR THE TREATMENT OF PAIN ASSOCIATED WITH MUSCLE ACTIVITY OR CONTRACTURE

Rice plant having vaccine gene transferred thereinto

Recombinant toxin fragments

Methods for preventing or ameliorating West Nile encephalitis

Methods for prevention or amelioration of West Nile encephalitis using a West Nile DNA vaccine

West Nile vaccine

West Nile vaccine

West Nile vaccine

Polysaccharide-protein conjugate vaccines

ANTIBODY PRODUCTION IN FARM ANIMALS

Multi-step therapy for injured muscles

Vaccine delivery

Vaccine Comprising a Polysaccharide Antigen-Carrier Protein Conjugate and Free Carrier Protein

Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy

Injectable vaccines against multiple meningococcal serogroups

Pharmaceutical compositions containing botulinum toxin

Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine

Escherichia coli-derived vaccine and therapy against botulism

Recombinant vaccine against botulinum neurotoxin

Antibodies to dendritc cells and human dendritic cell populations and uses thereof

Biologically active hemagglutinin from type A and methods of use

Methods and compositions to enhance immune responses via recall antigens

Delivery of therapeutics to the brain and spinal cord

alpha toxoid vaccine